Announcement on the Resignation of a Director and General Manager and the Chairman's Assumption of the General Manager's Duties
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2026-034
Beijing Wantai Biopharmaceutical Co., Ltd.
Regarding the resignation of the director and general manager
Announcement on the Chairman’s acting as the General Manager
The board of directors and all directors of the company guarantee that the contents of this announcement do not contain any false records or misleading
陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。
Important content reminder:
The board of directors of Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") recently received a written resignation report submitted by Ms. JIANGZHIMING, the company's director and general manager. Ms. JIANGZHIMING applied to resign from the company's relevant positions as director, general manager and special committee of the board of directors due to personal reasons. After her resignation, she will no longer hold any position in the company. According to the Company Law of the People's Republic of China (hereinafter referred to as the "Company Law"), the Articles of Association and relevant regulations, the resignation report will take effect from the date it is delivered to the board of directors.
1. Basic circumstances of resignation
Do you want to continue on? Is there any unused
Original term
姓名 离任职务 离任时间 离任原因 市公司及其控 履行完毕的到期日
Public commitments for holding positions in shareholding companies
Director, General Manager
理、战略与 否，不存在未JIANG 可持续发展 2026 年7 2027 年4 履行完毕的
Personal reasons No
ZHIMING Committee Committee Committee Committee members on January 2nd and 18th, public commitment (including members, nomination committee, shareholding increase commitment)
2. The impact of resignation on the company
According to the Company Law, Articles of Association and other relevant provisions, Ms. JIANGZHIMING's resignation will not cause the number of members of the company's board of directors and its special committees to fall below the legal minimum number, nor will it affect the normal operation of the company's board of directors and its special committees. Her resignation report will take effect immediately after it is delivered to the board of directors. As of the disclosure date of this announcement, Ms. JIANGZHIMING does not hold shares in the company, and there are no commitments that should be fulfilled but have not been fulfilled. Ms. JIANG ZHIMING promised to hand over the work in accordance with the company's relevant regulations.
In order to ensure the normal operation and management of the company, the company held the 17th meeting of the sixth board of directors on July 3, 2026, and reviewed and approved the "Proposal on Designating the Chairman to Act as the General Manager" and agreed that the chairman, Mr. Qiu Zixin, would act as the general manager during the vacancy of the company's general manager. The company will complete the selection of directors and general managers as soon as possible in accordance with the provisions of the Company Law and Articles of Association.
During her tenure as director and general manager of the company, Ms. JIANGZHIMING performed her duties diligently and diligently. The company and its board of directors would like to express their sincere gratitude to Ms. JIANG ZHIMING for her contribution to the development of the company during her tenure!
Announcement is hereby made.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
July 4, 2026